Posted on 12/7/2015
Senseonics Will Use New Investment to Fund US Trials
US based Senseonics has drummed up new investment from existing investments partners Anthem Capital, Greenspring Associates, Healthcare Ventures, Delphi Ventures and New Enterprise Associate. They raised $20 million which will be used to obtain a CE mark for its continuous glucose monitor, CGM, system, and also to fund the monitor’s upcoming investigational device exempt...